ABILITY PHARMA Trademark

Trademark Overview

On Monday, September 30, 2024, a trademark application was filed for ABILITY PHARMA with the United States Patent and Trademark Office. The USPTO has given the ABILITY PHARMA trademark a serial number of 79976020. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Tuesday, June 23, 2026. This trademark is owned by ABILITY PHARMACEUTICALS, S.A.. The ABILITY PHARMA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of cancer
ability pharma

General Information

Serial Number79976020
Word MarkABILITY PHARMA
Filing DateMonday, September 30, 2024
Status680 - APPROVED FOR PUBLICATION
Status DateTuesday, June 23, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"PHARMA"
Goods and ServicesPharmaceutical products for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 19, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameABILITY PHARMACEUTICALS, S.A.
Party Type10 - Original Applicant
Legal Entity Type85 - NOT AVAILABLE
AddressES

Trademark Events

Event DateEvent Description
Thursday, February 6, 2025SN ASSIGNED FOR SECT 66A APPL FROM IB
Wednesday, February 19, 2025LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, February 21, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 21, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, March 19, 2025ASSIGNED TO EXAMINER
Monday, March 24, 2025NON-FINAL ACTION WRITTEN
Tuesday, March 25, 2025NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 16, 2025REFUSAL PROCESSED BY MPU
Saturday, May 17, 2025NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, June 7, 2025REFUSAL PROCESSED BY IB
Monday, October 20, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 20, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 22, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 19, 2025FINAL REFUSAL WRITTEN
Wednesday, November 19, 2025FINAL REFUSAL E-MAILED
Wednesday, November 19, 2025NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, January 1, 2026LIMITATION OF GOODS RECEIVED FROM IB
Thursday, February 12, 2026LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, May 12, 2026TEAS REQUEST TO DIVIDE RECEIVED
Monday, May 18, 2026EXPARTE APPEAL RECEIVED AT TTAB
Monday, May 18, 2026JURISDICTION RESTORED TO EXAMINING ATTORNEY
Monday, May 18, 2026EX PARTE APPEAL-INSTITUTED
Monday, May 18, 2026TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, May 20, 2026ASSIGNED TO LIE
Monday, June 22, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 12, 2026DIVISIONAL REQUEST RECEIVED
Monday, June 22, 2026DIVISIONAL PROCESSING COMPLETE
Tuesday, June 23, 2026APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords

pharma ability cancer treatment products pharmaceutical